Literature DB >> 2876721

Interaction of cyclosporin and its solvent, Cremophor, with atracurium and vecuronium. Studies in the cat.

L Gramstad, J A Gjerløw, E S Hysing, H E Rugstad.   

Abstract

Interactions between Sandimmun (formulated as cyclosporin (CyA) in Cremophor and ethanol) and atracurium or vecuronium were investigated in anaesthetized cats. During stable 50% blockade and with a constant rate of infusion of the neuromuscular blocking drugs, Sandimmun 0.8 mg kg-1 or an equivalent amount of its solvent moiety was injected over 5 min. Sandimmun potentiated the blockade induced by vecuronium (median infusion rate 110 micrograms kg-1 h-1) from 50.7% before injection to maximum 95.2% 17.3 min after injection (median values), whereas the median blockade in cats receiving atracurium (median 250 micrograms kg-1 h-1) increased from 51.3% to 72.4% after 32.9 min. At 45 min after the injection the median blockades were 93.1% and 69.8%, respectively. In cats receiving vecuronium (median 104 micrograms kg-1 h-1) the solvent produced an increase in effect of from 51.1% to maximum 78.0% blockade after 5.4 min and 61.5% after 45 min (median values). Interaction with solvent was negligible in cats receiving atracurium. We attribute the effect of the solvent to the Cremophor component. The mechanism of the interaction related to the cyclosporin is unknown.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876721     DOI: 10.1093/bja/58.10.1149

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  10 in total

Review 1.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

2.  Does cyclosporine affect the duration of action of vecuronium in renal transplant recipients?

Authors:  Koichi Takita; Yukiko Goda; Osamu Kemmotsu; Atsushi Okuyama; Tadayoshi Ito; Hiroshi Sakamoto; Hideyuki Mashio; Hiroshi Kawahigashi
Journal:  J Anesth       Date:  1995-09       Impact factor: 2.078

3.  Anaesthesia for renal transplantation in sickle cell disease.

Authors:  H K Gyasi; A W Zarroug; M Matthew; R Joshi; A Daar
Journal:  Can J Anaesth       Date:  1990-10       Impact factor: 5.063

4.  Anaesthesia for non-cardiac surgery in heart-transplanted patients.

Authors:  D C Cheng; D D Ong
Journal:  Can J Anaesth       Date:  1993-10       Impact factor: 5.063

5.  Oral cyclosporine-vecuronium interaction.

Authors:  P Ganjoo; P Tewari
Journal:  Can J Anaesth       Date:  1994-10       Impact factor: 5.063

6.  Does vecuronium accumulate in the renal transplant patient?

Authors:  M A Starsnic; M E Goldberg; D E Ritter; A T Marr; M Sosis; G E Larijani
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

7.  Cyclosporine-pancuronium interaction in a patient with a renal allograft.

Authors:  E Crosby; J A Robblee
Journal:  Can J Anaesth       Date:  1988-05       Impact factor: 5.063

8.  Prolonged neuromuscular blockade and ventilatory failure after renal transplantation and cyclosporine.

Authors:  A Sidi; R F Kaplan; R F Davis
Journal:  Can J Anaesth       Date:  1990-07       Impact factor: 5.063

Review 9.  Adverse reactions and interactions of the neuromuscular blocking drugs.

Authors:  D Ostergaard; J Engbaek; J Viby-Mogensen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct

10.  Ischemia-Selective Cardioprotection by Malonate for Ischemia/Reperfusion Injury.

Authors:  Hiran A Prag; Dunja Aksentijevic; Andreas Dannhorn; Abigail V Giles; John F Mulvey; Olga Sauchanka; Luping Du; Georgina Bates; Johannes Reinhold; Duvaraka Kula-Alwar; Zhelong Xu; Luc Pellerin; Richard J A Goodwin; Michael P Murphy; Thomas Krieg
Journal:  Circ Res       Date:  2022-08-12       Impact factor: 23.213

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.